Inflammation predicts response to anti-depression medication

Younger people with bipolar disorder responded better to the antidepressant Latuda when they had increased inflammation biomarkers in their blood. Findings suggest C-reactive protein could be a predictive biomarker to identify which patients will respond to the antidepressant.